These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16392807)

  • 1. Novel transplatinum(II) complexes with [N2O2] donor sets. Cellular pharmacology and apoptosis induction in Pam 212-ras cells.
    Quiroga AG; Pérez JM; Alonso C; Navarro-Ranninger C; Farrell N
    J Med Chem; 2006 Jan; 49(1):224-31. PubMed ID: 16392807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
    Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
    J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro antitumor activity of platinum acetonimine complexes.
    Boccarelli A; Intini FP; Sasanelli R; Sivo MF; Coluccia M; Natile G
    J Med Chem; 2006 Jan; 49(2):829-37. PubMed ID: 16420068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.
    Ramos-Lima FJ; Moneo V; Quiroga AG; Carnero A; Navarro-Ranninger C
    Eur J Med Chem; 2010 Jan; 45(1):134-41. PubMed ID: 19853978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-Platinum planar amine compounds with [N2O2] ligand donor sets: effects of carboxylate leaving groups and steric hindrance on chemical and biological properties.
    Bulluss GH; Knott KM; Ma ES; Aris SM; Alvarado E; Farrell N
    Inorg Chem; 2006 Jul; 45(15):5733-5. PubMed ID: 16841974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of aqueous solubility and stability employing a trans acetate axis in trans planar amine platinum compounds while maintaining the biological profile.
    Ma ES; Bates WD; Edmunds A; Kelland LR; Fojo T; Farrell N
    J Med Chem; 2005 Sep; 48(18):5651-4. PubMed ID: 16134932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes.
    Aris SM; Gewirtz DA; Ryan JJ; Knott KM; Farrell NP
    Biochem Pharmacol; 2007 Jun; 73(11):1749-57. PubMed ID: 17418817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein.
    Margiotta N; Denora N; Ostuni R; Laquintana V; Anderson A; Johnson SW; Trapani G; Natile G
    J Med Chem; 2010 Jul; 53(14):5144-54. PubMed ID: 20568783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action II: contribution of drug inactivation, cellular drug uptake and sterical factors in the drug-target interaction to the antitumor activity.
    Schertl S; Hartmann RW; Batzl-Hartmann C; Bernhardt G; Spruss T; Beckenlehner K; Koch M; Krauser R; Schlemmer R; Gust R; Schönenberger H
    Arch Pharm (Weinheim); 2004 Jun; 337(6):349-59. PubMed ID: 15188224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands.
    Bielawski K; Bielawska A; Popławska B; Bołkun-Skórnicka U
    Acta Pol Pharm; 2008; 65(3):363-70. PubMed ID: 18646556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
    Benedetti BT; Quintal S; Farrell NP
    Dalton Trans; 2011 Nov; 40(41):10983-8. PubMed ID: 21918760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induction and inhibition of H-ras overexpression by novel trans-[PtCl2(isopropylamine)(amine')] complexes.
    Pérez JM; Montero EI; González AM; Alvarez-Valdés A; Alonso C; Navarro-Ranninger C
    J Inorg Biochem; 1999 Oct; 77(1-2):37-42. PubMed ID: 10626351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and biological activity of trans-platinum(II) and trans-platinum(IV) complexes with 4-hydroxymethylpyridine.
    Martínez A; Lorenzo J; Prieto MJ; de Llorens R; Font-Bardia M; Solans X; Avilés FX; Moreno V
    Chembiochem; 2005 Nov; 6(11):2068-77. PubMed ID: 16222727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.